Variant report
Variant | rs72940504 |
---|---|
Chromosome Location | chr2:85744906-85744907 |
allele | C/T |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:85733600-85750600 | Weak transcription | Duodenum Smooth Muscle | Duodenum |
2 | chr2:85734600-85750800 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
3 | chr2:85734600-85762000 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
4 | chr2:85742600-85745200 | Enhancers | Fetal Intestine Large | intestine |
5 | chr2:85742800-85745200 | Enhancers | Rectal Mucosa Donor 31 | rectum |
6 | chr2:85743200-85745600 | Enhancers | Stomach Mucosa | stomach |
7 | chr2:85743400-85745000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
8 | chr2:85743800-85745000 | Enhancers | Esophagus | oesophagus |
9 | chr2:85744000-85745000 | Weak transcription | K562 | blood |
10 | chr2:85744000-85750600 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
11 | chr2:85744200-85745000 | Enhancers | Pancreas | Pancrea |
12 | chr2:85744200-85745000 | Enhancers | Small Intestine | intestine |
13 | chr2:85744200-85745000 | Bivalent Enhancer | HepG2 | liver |
14 | chr2:85744400-85745200 | Enhancers | Hela-S3 | cervix |
15 | chr2:85744600-85745000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
16 | chr2:85744600-85745200 | Enhancers | A549 | lung |
17 | chr2:85744600-85747400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
18 | chr2:85744600-85750000 | Weak transcription | Colonic Mucosa | Colon |
19 | chr2:85744600-85750200 | Weak transcription | Fetal Intestine Small | intestine |